Results
eNauka >
Rezultati >
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Naziv  : | Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study | Autori  : | Singer, Barry A.; Arnold, Douglas L.; Drulović, Jelena S.  ; ...; (broj koautora 23) |
Godina: | 2023 | Publikacija: | Multiple sclerosis journal | ISSN: | 1352-4585 Multiple Sclerosis Pretraži identifikator |
Izdavač: | London : SAGE Publications | Tip rezultata: | Naučni članak | Kolacija: | vol. 29 br. 14 str. 1795-1807 | DOI: | 10.1177/13524585231205708 | WoS-ID: | 001095044200001 | Scopus-ID: | 2-s2.0-85176106509 | PMID: | 37905526 | PMCID: | PMC10687803 | URI: | https://enauka.gov.rs/handle/123456789/854397 | URL: | https://journals.sagepub.com/doi/10.1177/13524585231205708 | Projekat: | Some of these data have been previously presented at the 38th Congress of the European Committee for Treatment amp Research in Multiple Sclerosis (ECTRIMS), Amsterdam, Netherlands, 26-28 October 2022. |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.